Docetaxel Trihydrate CAS 148408-66-6 Ibikoresho bito bya Docetaxel Trihydrate

Ibisobanuro bigufi:

Docetaxel Trihydrate ni semisintetike igereranya ya paclitaxel yerekana ingaruka za gene ya bcl-2 na bcl-xL.Docetaxel Trihydrate ifata ingirabuzimafatizo ya G2 / M, biganisha kuri apoptose.Hande Bio itanga Docetaxel Trihydrate CAS 148408-66-6 ya Docetaxel Trihydrate. Kubindi bisobanuro, nyamuneka twandikire kumurongo.


Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Inyandiko

Numero ya CAS:114977-28-5

Imiti yimiti:C45H57NO14

Ibisobanuro:99%

Ibara:ifu yera

Inkomoko:Igice cya kabiri hamwe na 10-DAB

Ubwoko:APIs

Ubuzima bwa Shelf

Imiterere yububiko: ifunze, irinzwe kurumuri, yumutse, igenzurwa nubushyuhe bwicyumba

Ubushobozi bwo gukora

Inzira y'ibicuruzwa:Iminsi 7.

Ubushobozi bwo gutanga umusaruro:hariho ibarura, hariho inzira, kandi umusaruro mwinshi birashoboka.

Hande inzira ya GMP

1.Mu 1996, sisitemu yubuziranenge yashizweho kandi ibona DMF.

2.Mu 2004, FDA kugenzura kurubuga yabonye icyemezo cya CGMP.

3.Mu mwaka wa 2009, habonetse igice cya sintetike paclitaxel DMF na paclitaxel naturel ya CEP.

4.Mu mwaka wa 2011, habonetse igice cya sintetike paclitaxel CEP.

5.Mu mwaka wa 2012, yatsinze TGA ku igenzura, abona icyemezo cya GMP, anatsinda FDA ku igenzura.

6.Mu 2013, yatsinze urubuga rwa CGMP.

7.Mu 2015, Ubuhinde bwaranditswe kandi Ubuyapani bwiyandikisha.

Serivisi zacu

1.Ibicuruzwa:Tanga ibihingwa byujuje ubuziranenge, bifite isuku nyinshi, ibikoresho bya farumasi, hamwe naba farumasi.

2.Serivisi za tekiniki:Ibicuruzwa byabigenewe bifite ibisobanuro byihariye ukurikije ibyo umukiriya asabwa.

Uruganda

Ba umutanga mwiza wibikoresho fatizo ninganda zifite ubunyangamugayo!

Murakaza neza kundeba mwohereza imeri kurimarketing@handebio.com


  • Mbere:
  • Ibikurikira: